Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Testosterone |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Testosterone | Andriol | TES |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05011383 | Phase II | Testosterone | High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers (VA-BAT) | Recruiting | USA | 0 |
| NCT02286921 | Phase II | Enzalutamide Testosterone | Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance | Completed | USA | 0 |
| NCT02090114 | Phase II | Testosterone Abiraterone Enzalutamide | RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study) | Completed | USA | 0 |